Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of FructoseJOURNAL OF MEDICINAL CHEMISTRYIF6.82020-09-1051PREAI
Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1JOURNAL OF MEDICINAL CHEMISTRYIF6.82018-05-0226OAAI
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor (vol 60, pg 5673, 2017)JOURNAL OF MEDICINAL CHEMISTRYIF6.82018-04-060PREAI
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of NeuroinflammationJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-03-0268PREAI
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical CandidateJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-01-1621PREAI
Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol LipaseJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-12-0558PREAI
Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)JOURNAL OF MEDICINAL CHEMISTRYIF6.82017-09-1138PREAI
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A InhibitorJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-06-1626PREAI
Design, Synthesis, and Cytotoxic Evaluation of Novel Tubulysin Analogues as ADC PayloadsACS MEDICINAL CHEMISTRY LETTERSIF42016-09-0730OAAI
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in MetabolismACS CHEMICAL BIOLOGYIF3.82016-07-1917OAAI
A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective AntagonistsMOLECULAR PHARMACOLOGYIF32016-05-0191OAAI
The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N-{(3S,4S)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)JOURNAL OF MEDICINAL CHEMISTRYIF6.82015-05-1429PREAI
Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-04-0164OAAI
Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12015-03-0959OAAI
Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal ModificationsJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-12-09125PREAI
Discovery and Characterization of a Novel Dihydroisoxazole Class of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor PotentiatorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-11-1125PREAI
Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing InteractionsACS MEDICINAL CHEMISTRY LETTERSIF42012-11-0523OAAI
Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of β-Secretase (BACE1) through Fragment-Based Drug DesignJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-05-0971PREAI
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia精神分裂症的脑渗透,不可逆犬尿氨酸转氨酶II抑制剂的发现ACS MEDICINAL CHEMISTRY LETTERSIF42012-01-2579OA
Use of Structure-Based Design to Discover a Potent, Selective, In Vivo Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of SchizophreniaJOURNAL OF MEDICINAL CHEMISTRYIF6.82011-06-0854PREAI